The journal Blood has published a six-article series examining the current and future treatment of AML to guide the optimal individual treatment approach. The articles describe the current framework for the clinical management of patients with AML, including emerging therapeutic drugs for AML, targeted epigenetic therapy in AML, the evolving molecular landscape of AML and its clinical relevance, and allogeneic transplantation for patients with AML in first complete remission.
AML Review Series in Blood Highlights Latest Advances
Jan 2016